Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing
An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10